[1] 张爱华,朱春华.儿童紫癜性肾炎诊治进展[J].中华实用儿科临床杂志,2017,32(5):324-327. [2] 中华医学会儿科学分会肾脏病学组 . 儿童常见肾脏疾病诊治循证指南(二):紫癜性肾炎的诊治循证指南(试行)[J]. 中华儿科杂志, 2009, 47(12):911-913. [3] Iqbal SF, Freishtat RJ. Mechanism of action of vitamin D in the asthmatic lung[J]. J Investig Med, 2011, 59(8):1200-1202. [4] 王一,廖宏伟,宋扬.血清VitD、FA水平与三阴乳腺癌患者新辅助化疗敏感性关系[J].实用预防医学,2018,25(4):405-408. [5] Holick MF.Vitamin D deficiency[J].N Engl J Med,2007,357(3):266-281. [6] Ozen S,Ruperto N,Dillon MJ,et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides[J].Ann Rheum Dis,2006,65(7):936-941. [7] Calvo-Rio V, Loricera J, Mate C, et al. Henoch-Schönlein purpura in northern Spain: clinical spectrum of the disease in 417 patients from a single center[J]. Medicine, 2014, 93(2):106-113. [8] Kawasaki Y, Ono A, Ohara S, et al. Henoch-Schönlein purpura nephritis in childhood: pathogenesis, prognostic factors and treatment[J]. Fukushima J Med Sci, 2013, 59(1):15-26. [9] 唐雪梅. 过敏性紫癜病因及免疫发病机制 [J]. 实用儿科临床杂志, 2012, 27(21):1634-1636. [10] 李爽.过敏性紫癜"阳络伤"与免疫失衡关系的研究[C].中华中医药学会儿科分会第三十二次学术大会论文集,2015:327-329. [11] Li YY, Li CR, Wang GB, et al.Investigation of the change in CD4+ T cell subset in children with Henoch-Schonlein purpura[J].Rheumatol Int,2012,32(12):3785-3792. [12] 范秋霞,王春美,盛光耀.Thl7细胞和白细胞介素一17在儿童过敏 性紫癜发病中作用[J].中华实用诊断与治疗杂志,2010,24(11): 1089-1090. [13] Rostoker G,Rymer JC,Bagnard G,et aI.Imbalances in serum proinflammatory cytokines and their soluble receptors:a putative role in the progression of idiopathic IgA nephropathy(IgAN) and Henoch–Scnönlein purpura nephritis, and a potential target of immunoglobulin therapy[J].Clin Exp lmmunol,1998,114(3):468-476. [14] 刘文东,于凌翔,薛爱红,等 . 过敏性紫癜血清 TNF-α、IL-4和IL-6的变化及临床意义 [J]. 中国儿童保健杂志, 2011,19(1):77-80. [15] 陈冬平.紫癜性肾炎患者血清中TNF-α、TGF-β1和IL-6表达及其临床意义[J].中国老年学杂志,2010,30(15):2217-2218. [16] 彭霄,贺宏丽.维生素D在脓毒症免疫调节中的作用研究进展[J].中华危重病急救医学,2014,26 (3):206-208. [17] 李金潺,卫丹丹.维生素D在自身免疫性疾病中的作用[J].中国全科医学,2015,(18):2184-2187. [18] 刘靖华.过敏性紫癜患儿血清25-羟维生素D水平变化[J] .医学理论和实践,2018,10(4):1001-7585. [19] 权志慧,夏成云,张国云,等.狼疮性肾炎患者狼疮活动度与血清维生素D水平变化及意义[J].国际泌尿系统杂志,2015,35(2):187-190. [20] Li YC.Podocytes as target of vitamin D[J].Curr Diabetes Rev,2011,7(1):35-40. [21] Barreto DV,Barreto FC,Liabeuf S,et al. Vitamin D affects survival independently of vascular calcification in chronic kidney disease[J].Clin J Am Soc Nephrol,2009,4(6):1128-1135. [22] Inaguma D, Nagaya H, Hara K, el al. Relationship between serum 1,25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease[J].Clin Exp Nephrol,2008,12(2):126-131. [23] Ravani P,Malberti F,Tripepi G,et al.Vitamin D levels and patient outcome in chronic kidney disease[J].Kidney Int,2009,75(1):88-95.
2019, Vol. 26 
